Edwards Lifesciences (EW) Estimates Raised at Jefferies Following 'Stellar' Q4
Jefferies analyst Raj Denhoy reiterated a Buy rating and $155 price target on Edwards Lifesciences (NYSE: EW) while raising estimates ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
